Vanessa Malier

Vanessa Malier

Director, Managing Partner, Kurma Partners

Vanessa Malier is a Partner of Kurma Partners since 2013. Prior to Kurma, Malier was Vice President, R&D Strategic Planning at Ipsen, heading project and portfolio management as well as…

Simon Hirst

Simon Hirst

Director, CEO and founder of Sygnature Discovery

Simon is Sygnature’s Founder, Chief Executive Officer and chair of the Board of Directors. He is a medicinal chemist with 30 years’ experience in the pharmaceutical industry. Simon has been…

Louis Nisbet

Louis Nisbet

Director, Serial entrepreneur, Venture Partner with Kurma Partners

Louis J. Nisbet DSc PhD is a Venture Partner with Kurma Life Sciences Partners. An experienced health industry professional, Dr Nisbet operated at senior levels in R&D with Roche, Glaxo…

Romain Marlange

Romain Marlange

Director, Head of technology development at Imagine Institute

Romain is head of technology development at Imagine Institute, a world class translational institute dedicated to genetic diseases.  He has 15 years of experience in technology transfer and biomedical innovation…

François Thomas

François Thomas

Director, Managing director Inserm Transfert Initiative

François Thomas has more than 25 years of experience in the life sciences sector. Before becoming Manager Partner at Inserm Transfert Initiative in 2014, he held management positions at Ipsen…

Thibaut Roulon

Thibaut Roulon

Director, Investment director, BPI France Investissements

Thibaut started his career as a scientist at in a US biotech company developing cancer immunotherapeutics. In 2005 he joined Bioam Gestion, a venture capital firm investing in life science…

Hans Schambye

Hans Schambye

Chairman of the Board, Independent Director, CEO Galecto Biotech

Hans Schambye is a seasoned biotech entrepreneur with extensive experience in drug discovery and development. Previously, Dr. Schambye served as the Chief Executive Officer of ReceptIcon from 2006 to 2009…

Jacky Vonderscher

Jacky Vonderscher

Independent Director, CEO of Enyo Pharma

Jacky Vonderscher is an expert of exploratory research and new molecules’ early development. Before joining Roche laboratories in 2008 as global Chairman of translational research sciences at the company’s headquarters…

Erik Van Den Berg

Erik Van Den Berg

Independent Director, CEO of AM Pharma

Erik has over seventeen years experience in the pharmaceutical and biotechnology industries. He joined AM-Pharma in September 2007 as Chief Business Officer and became the company's CEO in 2011. Previously, as…

Ohad Hammer

Ohad Hammer

Observer, Partner, Pontifax

Ohad is a Partner at Pontifax, where he is in charge of scouting and project evaluation. In his role at Pontifax, Ohad is also involved in the formation and development strategy…